Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Vernalis (Apokyn & Vernalis US Commercial Operations)
Vernalis (Apokyn & Vernalis US Commercial Operations) Overview
Latest Deal Type
Vernalis (Apokyn & Vernalis US Commercial Operations) General Information
Developer of pharmaceutical products headquartered in Wokingham, England. The company develops and applies fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against targets in oncology, neurodegeneration, anti-infectives, inflammation and integrates fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both established and novel targets.